Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-18-003215
Accepted
2018-12-24 00:16:49
Documents
1
Effectiveness Date
2018-12-21
Registration Form
S-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 600
  Complete submission text file 9999999995-18-003215.txt   2061
Mailing Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Filer) CIK: 0001348911 (see all company filings)

EIN.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: EFFECT | Act: 33 | File No.: 333-228831 | Film No.: 181251139
SIC: 2834 Pharmaceutical Preparations